These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 25919246)
1. A Prospective, Split-Face, Randomized, Double-Blind Study Comparing OnabotulinumtoxinA to IncobotulinumtoxinA for Upper Face Wrinkles. Yeilding RH; Fezza JP Plast Reconstr Surg; 2015 May; 135(5):1328-1335. PubMed ID: 25919246 [TBL] [Abstract][Full Text] [Related]
2. Phase IV study comparing incobotulinumtoxinA and onabotulinumtoxinA using a 1:1.5 dose-conversion ratio for the treatment of glabellar frown lines. Prager W; Rappl T J Cosmet Dermatol; 2012 Dec; 11(4):267-71. PubMed ID: 23174049 [TBL] [Abstract][Full Text] [Related]
3. A Randomized, Double-Blind Trial to Investigate the Equivalence of IncobotulinumtoxinA and OnabotulinumtoxinA for Glabellar Frown Lines. Kane MA; Gold MH; Coleman WP; Jones DH; Tanghetti EA; Alster TS; Rohrer TE; Burgess CM; Shamban AT; Finn E Dermatol Surg; 2015 Nov; 41(11):1310-9. PubMed ID: 26509943 [TBL] [Abstract][Full Text] [Related]
4. Two different types of botulinum toxins: Is there a difference in efficacy and longevity? Shome D; Kapoor R; Khare S J Cosmet Dermatol; 2019 Dec; 18(6):1635-1641. PubMed ID: 31135088 [TBL] [Abstract][Full Text] [Related]
5. Effect of botulinum toxin pretreatment on laser resurfacing results: a prospective, randomized, blinded trial. Zimbler MS; Holds JB; Kokoska MS; Glaser DA; Prendiville S; Hollenbeak CS; Thomas JR Arch Facial Plast Surg; 2001; 3(3):165-9. PubMed ID: 11497500 [TBL] [Abstract][Full Text] [Related]
6. Clinical Evaluation of a Topical Unani Polyherbal Formulation in the Management of Photodamaged Facial skin: An open-label Standard Controlled Trial. Bibi C; Nigar Z Altern Ther Health Med; 2024 Mar; 30(3):16-23. PubMed ID: 38518171 [TBL] [Abstract][Full Text] [Related]
7. Does Linear or Spot Injection Technique Matter in Upper Face Botulinum Toxin Type A Application? A Split-Face Randomized Trial. Li Y; Sun Y; Lan X; Wu T; Xiao Y; Xia Z; Wang HC; Yu N; Wang X; Long X Plast Reconstr Surg; 2024 Oct; 154(4):656e-665e. PubMed ID: 37184512 [TBL] [Abstract][Full Text] [Related]
8. A randomised, double-blind comparison of 20 units of onabotulinumtoxinA with 30 units of incobotulinumtoxinA for glabellar lines. Moers-Carpi M; Dirschka T; Feller-Heppt G; Hilton S; Hoffmann K; Philipp-Dormston WG; Rütter A; Tan K; Chapman MA; Fulford-Smith A J Cosmet Laser Ther; 2012 Dec; 14(6):296-303. PubMed ID: 23057624 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the Clinical Efficacy of Abobotulinumtoxin A (ABO) and Onabotulinumtoxin A (ONA) in the Treatment of Crow's Feet Wrinkles: A Split-Face Study. Elridy AS; Zaki RGE; Elshinawy RF Semin Ophthalmol; 2018; 33(6):739-747. PubMed ID: 29278961 [TBL] [Abstract][Full Text] [Related]
10. Phase 3 Study of OnabotulinumtoxinA Distributed Between Frontalis, Glabellar Complex, and Lateral Canthal Areas for Treatment of Upper Facial Lines. De Boulle K; Werschler WP; Gold MH; Bruce S; Sattler G; Ogilvie P; Street J; Larsen KE; Yushmanova I; Lei X; Lee E; Vitarella D; Mao C Dermatol Surg; 2018 Nov; 44(11):1437-1448. PubMed ID: 30096106 [TBL] [Abstract][Full Text] [Related]
11. Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines. Lowe NJ; Shah A; Lowe PL; Patnaik R J Cosmet Laser Ther; 2010 Apr; 12(2):106-11. PubMed ID: 20151785 [TBL] [Abstract][Full Text] [Related]
12. A Prospective, Neurophysiologic Comparative Study to Assess the Efficacy and Duration of Effect of IncobotulinumtoxinA and AbobotulinumtoxinA in the Treatment of Crow's Feet. Saybel A; Artemenko A; Nikitin S; Kurenkov A J Drugs Dermatol; 2015 Nov; 14(11):1291-6. PubMed ID: 26580879 [TBL] [Abstract][Full Text] [Related]
13. A Quantitative Analysis of OnabotulinumtoxinA, AbobotulinumtoxinA, and IncobotulinumtoxinA: A Randomized, Double-Blind, Prospective Clinical Trial of Comparative Dynamic Strain Reduction. Wilson AJ; Chang B; Taglienti AJ; Chin BC; Chang CS; Folsom N; Percec I Plast Reconstr Surg; 2016 May; 137(5):1424-1433. PubMed ID: 27119918 [TBL] [Abstract][Full Text] [Related]
14. The South American Glabellar Experience Study (SAGE): a multicenter retrospective analysis of real-world treatment patterns following the introduction of incobotulinumtoxinA in Argentina. Banegas RA; Farache F; Rancati A; Chain M; Gallagher CJ; Chapman MA; Caulkins CA Aesthet Surg J; 2013 Sep; 33(7):1039-45. PubMed ID: 23990584 [TBL] [Abstract][Full Text] [Related]
15. OnabotulinumtoxinA (Botox) in the Treatment of Crow's Feet Lines in Japanese Subjects. Harii K; Kawashima M; Furuyama N; Lei X; Hopfinger R; Lee E Aesthetic Plast Surg; 2017 Oct; 41(5):1186-1197. PubMed ID: 28733805 [TBL] [Abstract][Full Text] [Related]
16. Quantitative evaluation of the onset and longevity of the action of incobotulinumtoxinA by skin displacement analysis in the treatment of glabellar frown lines. Proebstle TM; Chung G; Weissberg R; Pavicic T J Drugs Dermatol; 2014 Sep; 13(9):1067-72. PubMed ID: 25226007 [TBL] [Abstract][Full Text] [Related]
17. Full-face treatment with onabotulinumtoxinA: Results from a single-center study. D'Emilio R; Rosati G J Cosmet Dermatol; 2020 Apr; 19(4):809-816. PubMed ID: 31486568 [TBL] [Abstract][Full Text] [Related]
18. Statistical Analysis of "A Prospective, Split-Face, Randomized, Double-Blind Study Comparing OnabotulinumtoxinA to IncobotulinumtoxinA for Upper Face Wrinkles". Lorenc ZP Plast Reconstr Surg; 2016 Oct; 138(4):759e-760e. PubMed ID: 27307332 [No Abstract] [Full Text] [Related]
19. Botulinum A toxin for glabellar wrinkles. Dose and response. Hankins CL; Strimling R; Rogers GS Dermatol Surg; 1998 Nov; 24(11):1181-3. PubMed ID: 9834736 [TBL] [Abstract][Full Text] [Related]
20. [Botulinum toxin A in the treatment of the wrinkles in the upper third of the face]. Gassia V Ann Dermatol Venereol; 2008 Feb; 135 Suppl 3():S175-80. PubMed ID: 18342124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]